Redeye provides its comments on CLS’ Q1’22 report. With ongoing discussions with potential new commercial partners in the urology segment, three new clinical studies initiated as well as a pending 510(k) approval for the second generation of TRANBERG Thermal Therapy System with Thermoguide Workstation, the company has an interesting period ahead.